Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giovanni Paganelli

Showing results (61-70 of 180) with videos related to

Pageof 18
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2014
177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II studyGiovanni Paganelli, Maddalena Sansovini, Alice Ambrosetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I studyLisa Bodei, Marta Cremonesi, Stefania Zoboli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2006
Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT)Nicoletta Urbano, Stefano Papi, Mauro Ginanneschi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical studyFrancesca Botta, Marta Cremonesi, Mahila E Ferrari, et al.
Journal of Surgical Oncology|March 3, 2004
Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspectiveGiuliano Mariani, Paola Erba, Giuseppe Villa, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality IssueValentina Di Iorio, Stefano Boschi, Anna Sarnelli, et al.
Annals of Surgery|January 15, 2005
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsyGiuseppe Viale, Eugenio Maiorano, Giancarlo Pruneri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2008
Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatmentMarta Cremonesi, Mahila Ferrari, Mirco Bartolomei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumorsValentina Ambrosini, Davide Campana, Lisa Bodei, et al.
Current Cancer Drug Targets|May 14, 2008
Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancerConcetta De Cicco, Laura Ravasi, Laura Zorzino, et al.
Pageof 18

Showing results (61-70 of 180) with videos related to

Sort By:
Pageof 18
European Journal of Nuclear Medicine and Molecular Imaging|March 12, 2014
177 Lu-Dota-octreotate radionuclide therapy of advanced gastrointestinal neuroendocrine tumors: results from a phase II studyGiovanni Paganelli, Maddalena Sansovini, Alice Ambrosetti, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 29, 2003
Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I studyLisa Bodei, Marta Cremonesi, Stefania Zoboli, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 7, 2006
Evaluation of a new biotin-DOTA conjugate for pretargeted antibody-guided radioimmunotherapy (PAGRIT)Nicoletta Urbano, Stefano Papi, Mauro Ginanneschi, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 4, 2013
Investigation of 90Y-avidin for prostate cancer brachytherapy: a dosimetric model for a phase I-II clinical studyFrancesca Botta, Marta Cremonesi, Mahila E Ferrari, et al.
Journal of Surgical Oncology|March 3, 2004
Lymphoscintigraphic and intraoperative detection of the sentinel lymph node in breast cancer patients: the nuclear medicine perspectiveGiuliano Mariani, Paola Erba, Giuseppe Villa, et al.
Pharmaceuticals (Basel, Switzerland)|July 2, 2021
[<sup>18</sup>F]F-PSMA-1007 Radiolabelling without an On-Site Cyclotron: A Quality IssueValentina Di Iorio, Stefano Boschi, Anna Sarnelli, et al.
Annals of Surgery|January 15, 2005
Predicting the risk for additional axillary metastases in patients with breast carcinoma and positive sentinel lymph node biopsyGiuseppe Viale, Eugenio Maiorano, Giancarlo Pruneri, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2008
Radioembolisation with 90Y-microspheres: dosimetric and radiobiological investigation for multi-cycle treatmentMarta Cremonesi, Mahila Ferrari, Mirco Bartolomei, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 17, 2010
68Ga-DOTANOC PET/CT clinical impact in patients with neuroendocrine tumorsValentina Ambrosini, Davide Campana, Lisa Bodei, et al.
Current Cancer Drug Targets|May 14, 2008
Circulating levels of VCAM and MMP-2 may help identify patients with more aggressive prostate cancerConcetta De Cicco, Laura Ravasi, Laura Zorzino, et al.
Pageof 18